BMB Reports : eISSN 1976-670X

Cited by CrossRef (36)

  1. Lu Zhang, Liang Kong, Si-yu He, Xin-ze Liu, Yang Liu, Juan Zang, Rui-jun Ju, Xue-tao Li. The anti-ovarian cancer effect of RPV modified paclitaxel plus schisandra B liposomes in SK-OV-3 cells and tumor-bearing mice. Life Sciences 2021;285:120013
    https://doi.org/10.1016/j.lfs.2021.120013
  2. O. I. Aleshikova, N. A. Babaeva, E. V. Gerfanova, I. B. Antonova, V. O. Shender, A.  E. Babaeva, L. A. Ashrafyan. Ovarian cancer, malignant ascites and microenvironment. Literature review. jour 2023;14:21
    https://doi.org/10.47093/2218-7332.2023.14.2.21-30
  3. Lingling Zhuang, Xu Ming, Jun Liu, Chao Jia, Yubiao Jin, Jing Wang, Qiusheng Shi, Rong Wu, Lifang Jin, Lianfang Du. Comparison of lymphatic contrast-enhanced ultrasound and intravenous contrast-enhanced ultrasound in the preoperative diagnosis of axillary sentinel lymph node metastasis in patients with breast cancer. BJR 2022;95
    https://doi.org/10.1259/bjr.20210897
  4. Mengdi Song, Mingxiao Cui, Kehai Liu. Therapeutic strategies to overcome cisplatin resistance in ovarian cancer. European Journal of Medicinal Chemistry 2022;232:114205
    https://doi.org/10.1016/j.ejmech.2022.114205
  5. Haitao Hu, Ting Ma, Nanqi Liu, Hong Hong, Lujiao Yu, Dantong Lyu, Xin Meng, Biao Wang, Xuefeng Jiang. Immunotherapy checkpoints in ovarian cancer vasculogenic mimicry: Tumor immune microenvironments, and drugs. International Immunopharmacology 2022;111:109116
    https://doi.org/10.1016/j.intimp.2022.109116
  6. Xuejun He, Jijun You, Haibing Ding, Zhisheng Zhang, Lin Cui, Xiaomei Shen, Xiaoxia Bian, Yanqing Liu, Jue Chen. Vasculogenic mimicry, a negative indicator for progression free survival of lung adenocarcinoma irrespective of first line treatment and epithelial growth factor receptor mutation status. BMC Cancer 2021;21
    https://doi.org/10.1186/s12885-021-07863-z
  7. Marisol Salgado-Albarrán, Julian Späth, Rodrigo González-Barrios, Jan Baumbach, Ernesto Soto-Reyes. CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy. npj Syst Biol Appl 2022;8
    https://doi.org/10.1038/s41540-022-00214-z
  8. Young Ju Suh, Banghyun Lee, Kidong Kim, Yujin Jeong, Hwa Yeon Choi, Sung Ook Hwang, Yong Beom Kim. Bevacizumab versus PARP-inhibitors in women with newly diagnosed ovarian cancer: a network meta-analysis. BMC Cancer 2022;22
    https://doi.org/10.1186/s12885-022-09455-x
  9. Maria Sol Recouvreux, Jiangyong Miao, Maricel C. Gozo, Jingni Wu, Ann E. Walts, Beth Y. Karlan, Sandra Orsulic. FOXC2 Promotes Vasculogenic Mimicry in Ovarian Cancer. Cancers 2022;14:4851
    https://doi.org/10.3390/cancers14194851
  10. Ping Yu, Yaru Wang, Dahai Yuan, Yunqin Sun, Shuang Qin, Tianye Li. Vascular normalization: reshaping the tumor microenvironment and augmenting antitumor immunity for ovarian cancer. Front. Immunol. 2023;14
    https://doi.org/10.3389/fimmu.2023.1276694
  11. Chunmei Zhang, Meiying Qin. Extracellular vesicles targeting tumor microenvironment in ovarian cancer. International Journal of Biological Macromolecules 2023;252:126300
    https://doi.org/10.1016/j.ijbiomac.2023.126300
  12. Xiao-Yuan Li, Yang Rao, Bing Sun, Xue-Mei Mao. Efficacy and Safety of Anlotinib Combined with PD-1 Blockades for Patients with Previously Treated Epithelial Ovarian Cancer: A Retrospective Study. IJGM 2022;Volume 15:3977
    https://doi.org/10.2147/IJGM.S352536
  13. Iljin Kim, Sanga Choi, Seongkyeong Yoo, Mingyu Lee, Jong-Wan Park. AURKB, in concert with REST, acts as an oxygen-sensitive epigenetic regulator of the hypoxic induction of MDM2. BMB Rep 2022;55:287
    https://doi.org/10.5483/BMBRep.2022.55.6.017
  14. Yu-Jia Wang, Ling Tang, Xu-Hong Lu, Ji-Tao Liu, Yuan-Yuan Wang, Hong-Xia Geng, Xue-Tao Li, Quan An. Efficacy of epi-1 modified epirubicin and curcumin encapsulated liposomes targeting-EpCAM in the inhibition of epithelial ovarian cancer cells. Journal of Liposome Research 2023;33:197
    https://doi.org/10.1080/08982104.2022.2153138
  15. Zhihao Zhao, Qilin Wang, Fang Zhao, Junnan Ma, Xue Sui, Hyok Chol Choe, Peng Chen, Xue Gao, Lin Zhang. Single-cell and transcriptomic analyses reveal the influence of diabetes on ovarian cancer. BMC Genomics 2024;25
    https://doi.org/10.1186/s12864-023-09893-2
  16. Ying Shao, Bingjian Lu. The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers. Cancer Metastasis Rev 2022;41:173
    https://doi.org/10.1007/s10555-021-10000-8
  17. Jennifer Griessinger, Julian Schwab, Qian Chen, Anna Kühn, Jonathan Cotton, Gregory Bowden, Heike Preibsch, Gerald Reischl, Leticia Quintanilla-Martinez, Hidetoshi Mori, An Nguyen Dang, Ursula Kohlhofer, Olulanu H. Aina, Alexander D. Borowsky, Bernd J. Pichler, Robert D. Cardiff, Andreas M. Schmid. Intratumoral in vivo staging of breast cancer by multi-tracer PET and advanced analysis. npj Breast Cancer 2022;8
    https://doi.org/10.1038/s41523-022-00398-x
  18. Banghyun Lee, Suk-Joon Chang, Byung Su Kwon, Joo-Hyuk Son, Myong Cheol Lim, Yun Hwan Kim, Shin-Wha Lee, Chel Hun Choi, Kyung Jin Eoh, Jung-Yun Lee, Dong Hoon Suh, Yong Beom Kim. Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines. J Gynecol Oncol 2024;35
    https://doi.org/10.3802/jgo.2024.35.e43
  19. Xinyuan Tian, Qin Si, Menghe Liu, Jianping Shi, Rongwei Zhao, Yang Xiong, Lei Yu, Hongwei Cui, Haibin Guan. Advance in vasculogenic mimicry in ovarian cancer (Review). Oncol Lett 2023;26
    https://doi.org/10.3892/ol.2023.14043
  20. Xinyu Lin, Sheng Long, Congcong Yan, Xiaofeng Zou, Guoxi Zhang, Junrong Zou, Gengqing Wu. Therapeutic potential of vasculogenic mimicry in urological tumors. Front. Oncol. 2023;13
    https://doi.org/10.3389/fonc.2023.1202656
  21. Yarely M. Salinas-Vera, Dolores Gallardo-Rincón, Erika Ruíz-García, Laurence A. Marchat, Jesús Valdés, Carlos Vázquez-Calzada, César López-Camarillo. Vasculogenic Mimicry. 2023.
    https://doi.org/10.1007/978-1-0716-2403-6_6
  22. Bicai Tang, Wenjuan Ma, Yunfeng Lin. Emerging applications of anti-angiogenic nanomaterials in oncotherapy. Journal of Controlled Release 2023;364:61
    https://doi.org/10.1016/j.jconrel.2023.10.022
  23. A. Y. Shamanova, E. L. Kazachkov, I. E. Panova, V. V. Saevets, L. V. Yarina, T. N. Shamaeva, V. M. Vlasova. Prognostic value of macrophage vasculiform mimicry in the evaluation of uveal melanoma progression. jour 2023;22:56
    https://doi.org/10.52420/2071-5943-2023-22-2-56-64
  24. Vanja Tadić, Wei Zhang, Anamaria Brozovic. The high-grade serous ovarian cancer metastasis and chemoresistance in 3D models. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024;1879:189052
    https://doi.org/10.1016/j.bbcan.2023.189052
  25. Ming Wang, Shanfa Ren, Zhun Bi, Liang Zhang, Mengqi Cui, Ronghao Sun, Jiali Bao, Dandi Gao, Bo Yang, Xiaoping Li, Mingjiang Li, Ting Xiao, Hong‐gang Zhou, Cheng Yang. Myricetin reverses epithelial–endothelial transition and inhibits vasculogenic mimicry and angiogenesis of hepatocellular carcinoma by directly targeting PAR1. Phytotherapy Research 2022;36:1807
    https://doi.org/10.1002/ptr.7427
  26. Yurou Ji, Qi Ge, Wenwen Zhang, Pengpeng Qu. Molecular Features, Prognostic Value, and Cancer Immune Interactions of Angiogenesis-Related Genes in Ovarian Cancer. Reprod. Sci. 2023;30:1637
    https://doi.org/10.1007/s43032-022-01123-6
  27. Guoqiang Chen, Lei Qiu, Jinghai Gao, Jing Wang, Jianhong Dang, Lingling Li, Zhijun Jin, Xiaojun Liu. Stress Hormones: Emerging Targets in Gynecological Cancers. Front. Cell Dev. Biol. 2021;9
    https://doi.org/10.3389/fcell.2021.699487
  28. Tao Pu, Yawei Liu, Yuetian Pei, Jing Peng, Zehua Wang, Ming Du, Qiyu Liu, Fangfang Zhong, Mingxing Zhang, Fuyou Li, Congjian Xu, Xiaoyan Zhang. NIR-II Fluorescence Imaging for the Detection and Resection of Cancerous Foci and Lymph Nodes in Early-Stage Orthotopic and Advanced-Stage Metastatic Ovarian Cancer Models. ACS Appl. Mater. Interfaces 2023;15:32226
    https://doi.org/10.1021/acsami.3c04949
  29. Daniela B. Vera, Allison N. Fredes, Maritza P. Garrido, Carmen Romero. Role of Mitochondria in Interplay between NGF/TRKA, miR-145 and Possible Therapeutic Strategies for Epithelial Ovarian Cancer. Life 2021;12:8
    https://doi.org/10.3390/life12010008
  30. Xingyu Fan, Junfeng Huang, Bingqi Hu, Jing Zhou, Liwen Chen. Tumor-expressed B7-H3 promotes vasculogenic mimicry formation rather than angiogenesis in non-small cell lung cancer. J Cancer Res Clin Oncol 2023;149:8729
    https://doi.org/10.1007/s00432-023-04790-3
  31. Yusha Wang, Lei Zhang, Yun Bai, Li Wang, Xuelei Ma. Therapeutic implications of the tumor microenvironment in ovarian cancer patients receiving PD-1/PD-L1 therapy. Front. Immunol. 2022;13
    https://doi.org/10.3389/fimmu.2022.1036298
  32. Qiong Xu, Zequn Liu, Zhi-qin Zhu, Yue Fan, Rui Chen, Xiao-hui Xie, Mi Cheng. Knockdown of growth factor receptor bound protein 7 suppresses angiogenesis by inhibiting the secretion of vascular endothelial growth factor A in ovarian cancer cells. Bioengineered 2021;12:12179
    https://doi.org/10.1080/21655979.2021.2005225
  33. Jianguo Wang, Yan Liu, Yuanbin Zhang, Xiaoyang Li, Min Fang, Dong Qian. Targeting exosomes enveloped EBV‐miR‐BART1‐5p‐antagomiRs for NPC therapy through both anti‐vasculogenic mimicry and anti‐angiogenesis. Cancer Medicine 2023;12:12608
    https://doi.org/10.1002/cam4.5941
  34. Deok-Soo Han, Eun-Ok Lee. Sp1 Plays a Key Role in Vasculogenic Mimicry of Human Prostate Cancer Cells. IJMS 2022;23:1321
    https://doi.org/10.3390/ijms23031321
  35. Dansaem Lim, Jin Gu Cho, Eunsik Yun, Aram Lee, Hong-Yeoul Ryu, Young Joo Lee, Sukjoon Yoon, Woochul Chang, Myeong-Sok Lee, Byung Su Kwon, Jongmin Kim. MicroRNA 34a–AXL Axis Regulates Vasculogenic Mimicry Formation in Breast Cancer Cells. Genes 2020;12:9
    https://doi.org/10.3390/genes12010009
  36. Yingying Yuan, Bochao Geng, Xiaoyan Xu, Han Zhao, Jingyi Bai, Zhizhi Dou, Shaoyou Jia, Xiaoling Yu, Wenjuan Luo. Dual VEGF/PDGF knockdown suppresses vasculogenic mimicry formation in choroidal melanoma cells via the Wnt5a/β-catenin/AKT signaling pathway. Acta Histochemica 2022;124:151842
    https://doi.org/10.1016/j.acthis.2021.151842